5 Results for "

PARP1-IN-6

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "PARP1-IN-6" in MCE Product Catalog:

Cat. No.: HY-139879
CAS No.: 1654735-36-0
Target:  

PARP

Research Areas:  

Cancer

PARP1-IN-6 is a dual tubulin/PARP-1 inhibitor with IC50 values of 0.94 and 0.48 μM, respectively.
loading...
    loading...
Cat. No.: HY-119653
CAS No.: 1825345-33-2
Purity:  99.80%
Target:  

PARP

Research Areas:  

Cancer

AZ9482 is a triple PARP1/2/6 inhibitor, with IC50 values of 1 nM, 1 nM and 640 nM for PARP1, PARP2 and PARP6, respectively .
loading...
    loading...
Cat. No.: HY-145749
CAS No.: 2561483-27-8
Target:  

PARP

Research Areas:  

Cancer

PARPYnD is a PARP enzyme photoaffinity probe (AfBP) based on the triple PARP1/2/6 inhibitor AZ9482 (HY-119653), which induces breast cancer Formation of multipolar spindles (MPS) in cells. PARPYnD inhibits PAPR wih IC50 of 38 nM (PARP1), 6 nM (PARP2), 230 nM (PARP6), respectively. PARPYnD enriches recombinant PARP6 incorporated into cell lysates and inhibits PARP6 in cell-free assays, but it does not label PARP6 in intact cells .
loading...
    loading...
Cat. No.: HY-146160
CAS No.: 3032621-10-3
Target:  

PARP HDAC

Research Areas:  

Cancer

PARP-1/HDAC-IN-1 is a PARP-1/HDAC6 dual targeting inhibitor with IC50s of 68.90 nM and 510 nM, respectively. PARP-1/HDAC-IN-1 displays remarkable anticancer, anti-migration and anti-angiogenesis activities .
loading...
    loading...
Cat. No.: HY-181999
PC8 is a selective dual inhibitor of PARP1/CDK6, with an IC50 of 0.126 μM for PARP1 and 0.197 μM for CDK6. PC8 does not alter PARP1 expression, but reduces the expression of its downstream target PAR. PC8 inhibits the canonical Wnt/β-catenin signaling pathway. PC8 induces intracellular ROS accumulation and exacerbates DNA damage. PC8 inhibits the proliferation of triple-negative breast cancer (TNBC) cells. PC8 can be used for the research of triple-negative breast cancer .
loading...
    loading...